Subjective cognitive concerns, amyloid-β, and neurodegeneration in clinically normal elderly
Rebecca E. Amariglio(Harvard University), Dorene M. Rentz(Brigham and Women's Hospital), Gad A. Marshall, Patrizia Vannini(Harvard University), Elizabeth C. Mormino(Allen Institute for Brain Science), Reisa A. Sperling(Harvard University), Keith A. Johnson(Brigham and Women's Hospital), Alison Pietras(Anna Needs Neuroblastoma Answers)
Cited by 164
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k